Dr Deborah A Jeffries New Tryten Global Director of Healthcare

Dr Deborah A Jeffries is Tryten new Global Director of Healthcare. Dr. Deborah A. Jeffries (Dr. Deb) brings 25 years of expertise in medicine, education, telehealth, video conferencing, virtual training, patient care, and healthcare industry trends.

Dr. Deb did undergraduate and post-graduate work in physics at UCLA. She received her ND from NCNM. She taught pathology at NCC, as well as pathophysiology and hematology at Merrimac College.

Dr. Deb will be helping Tryten to launch multi-purpose (video-capable) cart/vehicles for telemedicine encounters, video remote interpreting, patient observation, and electronic health record workstations.

“It is so exciting to join the team at Tryten. Today the healthcare system is challenged like never before. Not only are we experiencing a major paradigm shift to healthcare that is focused on workflow efficiencies, practitioner availability, patient-centered care, digital health, and cost containment, but now we are faced with a rapidly evolving pandemic and how to respond to COVID-19 and the multiple complexities it brings. We need to immediately focus on how to help.”

Tony Janzen, founder, and CEO of Tryten states, “We are excited that Dr. Deb has joined our growing team. Dr. Deb brings a level of professionalism and knowledge that makes her so valuable to the growth and development of Tryten.”

Dr. Deb will be focused on healthcare solutions and supporting Tryten’s marketing and sales efforts.

SourceTryten

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”